The invention relates to novel bicyclic heterocycle derivatives of formula (I) wherein Cy1, Cy2, R1, R2 and L1 have the meaning given in the specification, and pharmaceutically acceptable salts thereof. The compounds of formula (I) are useful as bromodomain inhibitors in the treatment or prevention of diseases or disorders where bromodomain inhibition is desired.